fbpx
September 22, 2021

Childhood Trauma Linked to Adult Neurologic Disorders Childhood Trauma Linked to Adult Neurologic Disorders

Adult patients with headaches, epilepsy, or other neurologic disorders are more likely to have had adverse childhood experiences (ACEs) than the general public, new research suggests. […]
September 21, 2021

Surge in New-Onset Tics in Adults Tied to COVID-19 Stress Surge in New-Onset Tics in Adults Tied to COVID-19 Stress

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. An unusual surge of new-onset tics in patients with no prior history […]
September 21, 2021

Friedreich’s Ataxia Treatment Shows Extended Benefit Friedreich’s Ataxia Treatment Shows Extended Benefit

Dr David Lynch Omaveloxolone, an activator of the protein Nrf2 that protects against inflammation, has shown a potentially beneficial effect in slowing the progression of Friedreich’s […]
September 21, 2021

Survey Identifies Clinicians’ Unease With Genetic Testing in PD Survey Identifies Clinicians’ Unease With Genetic Testing in PD

Before getting to work on developing guidelines for genetic testing in Parkinson’s disease, a task force of the Movement Disorders Society surveyed members worldwide to identify […]
September 20, 2021

FDA Class I Recall for Medtronic’s Flex Embolization Devices FDA Class I Recall for Medtronic’s Flex Embolization Devices

Medtronic is recalling the Pipeline Flex embolization device and Pipeline Flex embolization device with shield technology because the delivery system’s wire and tubes could fracture and […]
September 19, 2021

Sublingual Film Well-Tolerated for Parkinson ‘Off’ Episodes Sublingual Film Well-Tolerated for Parkinson ‘Off’ Episodes

A majority of patients with Parkinson disease (PD) experiencing “off” episodes  successfully tolerated titration to an effective and tolerable dose of sublingual apomorphine film (SL-apo; Kynmobi, […]
September 17, 2021

Ticagrelor of Net Clinical Benefit aAfter Stroke, TIA: THALES Ticagrelor of Net Clinical Benefit aAfter Stroke, TIA: THALES

New evidence suggesting that the benefit of ticagrelor outweighs the risk when added to aspirin for 30 days after a mild-to-moderate ischemic stroke or high-risk transient […]
September 16, 2021

Nonopioid Med Promising for Neuropathic Pain Nonopioid Med Promising for Neuropathic Pain

Top-line results from a phase 2 study suggest vixotrigine (BIIB074, Biogen), a nonopioid investigational oral pain medication, reduces chronic neuropathic pain caused by small fiber neuropathy […]
September 16, 2021

CBD Gel a Promising Adjunct for Kids With Severe Epilepsy CBD Gel a Promising Adjunct for Kids With Severe Epilepsy

Topical cannabidiol (CBD) gel, added to antiseizure medication, may help reduce seizures and improve quality of life in children with developmental and epileptic encephalopathies, according to […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0